BIDEN ADMINISTRATION “MARCH-IN” POLICY

Throwing Gas on the IRA Fire That’s Burning Rare Disease Patients Hope   Washington, D.C. (12-12-2023) – On December 7th, the Biden administration announced its plans to clarify the Bayh-Dole Act, formally known as the Patent and Trademark Act Amendments,  and use the “march-in” clause to  re-license high priced drugs that had been a part of…